SCHEMBL9323648

SCHEMBL9323648

COC(=O)C1CCCN1CCCN(CCC(C)C)CCC(C)C

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ LTA4H P09960 2/20 0.42
▸ PEPD P12955 1/20 0.37
▸ NR1I2 O75469 1/20 0.36
▸ MMP3 P08254 1/20 0.35
▸ POLB P06746 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ GAA P10253 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ GBA1 P04062 1/20 0.34
▸ FKBP1A P62942 3/20 0.34
▸ ACE P12821 2/20 0.33
▸ ADRA1D P25100 1/20 0.33
▸ ADRA1A P35348 1/20 0.33
▸ ADRA1B P35368 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ REN P00797 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13995210 0.84 LTA4H (0.48) LTA4HPEPDMMP3POLBALDH1A1
SCHEMBL13995592 0.84 LTA4H (0.48) LTA4HPEPDMMP3POLBALDH1A1
SCHEMBL19571179 0.84 LTA4H (0.48) LTA4HPEPDMMP3POLBALDH1A1
SCHEMBL9288792 0.80 LTA4H (0.46) LTA4HPEPDNR1I2POLBALDH1A1
SCHEMBL4230937 0.78 LTA4H (0.48) LTA4HPEPDNR1I2POLBALDH1A1
SCHEMBL7833954 0.78 LTA4H (0.48) LTA4HPEPDNR1I2POLBALDH1A1
SCHEMBL4220647 0.78 LTA4H (0.48) LTA4HPEPDNR1I2POLBALDH1A1
SCHEMBL9323743 0.77 THRA (0.40) LTA4HPOLBALDH1A1GAARAB9A
SCHEMBL14115082 0.77 NR1I2 (0.54) LTA4HNR1I2POLBFKBP1A
SCHEMBL15434618 0.77 NR1I2 (0.54) LTA4HNR1I2POLBFKBP1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5310902-A Glutamate blockers NIPPON CHEMIPHAR CO., LTD. (JP) 1994-05-10 — — US disclosed
US-5070196-A GLUTAMATE BLOCKERS NIPPON CHEMIPHAR CO., LTD. (JP) 1991-12-03 — — US disclosed
Send feedback